-+ 0.00%
-+ 0.00%
-+ 0.00%

William Blair Upgrades Neumora Therapeutics to Outperform

Benzinga·02/17/2026 15:21:25
Listen to the news
William Blair analyst Myles Minter upgrades Neumora Therapeutics (NASDAQ:NMRA) from Market Perform to Outperform.